FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents composition containing vitamin B9, or folic acid, or folacin and myocardial inositol and alpha-lipoic acid for use in curative treating of polycystic ovary syndrome, sterility and menstrual disorders.
EFFECT: invention provides the synergetic effect in treating females with polycystic ovary syndrome, improved spontaneous ovulation activity and considerable increase of frequency of pregnancy.
6 cl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME | 2020 |
|
RU2757220C1 |
| POLYVITAMIN KIT FOR WOMEN | 2010 |
|
RU2443422C2 |
| COMPOSITION FOR IMPORVEMENT OF HUMAN REPRODUCTION | 2016 |
|
RU2616521C1 |
| METHOD FOR INCREASING THE FREQUENCY OF EMBRYO IMPLANTATION IN A FEMALE SUBJECT SUFFERING FROM POLYCYSTIC OVARIAN SYNDROME | 2018 |
|
RU2790696C2 |
| COMPOSITION FOR IMPROVEMENT OF THE MALE REPRODUCTIVE FUNCTION | 2017 |
|
RU2665636C2 |
| ORALLY SOLUBLE AND/OR EFFERVESCENT COMPOSITIONS, CONTAINING AT LEAST ONE S-ADENOSYLMETHYONINE (SAM) | 2010 |
|
RU2524645C2 |
| METHOD OF TREATING PATIENTS SUFFERING INFERTILITY CAUSED BY POLYCYSTIC OVARIAN DISEASE OF OVARIAN GENESIS WITH UNDERLYING CHRONIC AND ACUTE PELVIC INFLAMMATION | 2011 |
|
RU2466724C1 |
| TREATMENT OR PREVENTION OF OVARY HYPERSTIMULATION SYNDROME (OHSS) WITH APPLICATION OF DOPHAMINE AGONIST | 2006 |
|
RU2416410C2 |
| METHOD FOR CORRECTING REPRODUCTIVE HEALTH IN FEMALES | 2006 |
|
RU2314094C1 |
| COMPOSITION OF AGENT FOR RELIEVING OR REDUCING HANGOVER SYNDROME (VERSIONS) | 2023 |
|
RU2823336C1 |
